These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22418690)

  • 1. Cardiotrophin-1 in hypertensive heart disease.
    González A; López B; Ravassa S; Beaumont J; Zudaire A; Gallego I; Brugnolaro C; Díez J
    Endocrine; 2012 Aug; 42(1):9-17. PubMed ID: 22418690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats.
    Ishikawa M; Saito Y; Miyamoto Y; Harada M; Kuwahara K; Ogawa E; Nakagawa O; Hamanaka I; Kajiyama N; Takahashi N; Masuda I; Hashimoto T; Sakai O; Hosoya T; Nakao K
    J Hypertens; 1999 Jun; 17(6):807-16. PubMed ID: 10459879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure.
    González A; Ravassa S; Loperena I; López B; Beaumont J; Querejeta R; Larman M; Díez J
    J Hypertens; 2007 Oct; 25(10):2148-57. PubMed ID: 17885560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Rábago G; Díez J
    Hypertension; 2014 Mar; 63(3):483-9. PubMed ID: 24366078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications.
    López B; González A; Querejeta R; Barba J; Díez J
    J Hypertens; 2009 Feb; 27(2):418-24. PubMed ID: 19155793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development.
    Wollert KC; Chien KR
    J Mol Med (Berl); 1997 Jul; 75(7):492-501. PubMed ID: 9253712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes.
    Moreno MU; Eiros R; Gavira JJ; Gallego C; González A; Ravassa S; López B; Beaumont J; San José G; Díez J
    Med Clin North Am; 2017 Jan; 101(1):43-52. PubMed ID: 27884234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial remodeling in hypertension.
    Nadruz W
    J Hum Hypertens; 2015 Jan; 29(1):1-6. PubMed ID: 24804791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apoptosis in hypertensive cardiopathy].
    Díez J; Fortuño MA; Ravassa S
    Rev Esp Cardiol; 1999; 52 Suppl 3():18-24. PubMed ID: 10614145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotrophin-1. Review.
    Stejskal D; Ruzicka V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):9-19. PubMed ID: 18795069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease.
    Díez J; González A; López B; Querejeta R
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):209-16. PubMed ID: 16265485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention, diagnosis, and treatment of hypertensive heart disease.
    Georgiopoulou VV; Kalogeropoulos AP; Raggi P; Butler J
    Cardiol Clin; 2010 Nov; 28(4):675-91. PubMed ID: 20937450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance.
    Zolk O; Ng LL; O'Brien RJ; Weyand M; Eschenhagen T
    Circulation; 2002 Sep; 106(12):1442-6. PubMed ID: 12234945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension.
    López B; Castellano JM; González A; Barba J; Díez J
    Hypertension; 2007 Nov; 50(5):977-83. PubMed ID: 17846346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management.
    Fortuño MA; Ravassa S; Fortuño A; Zalba G; Díez J
    Hypertension; 2001 Dec; 38(6):1406-12. PubMed ID: 11751726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?
    Moreno MU; San José G; Pejenaute Á; Landecho MF; Díez J; Beloqui Ó; Fortuño A; Zalba G
    Hypertension; 2014 Mar; 63(3):468-74. PubMed ID: 24324051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways.
    Wollert KC; Taga T; Saito M; Narazaki M; Kishimoto T; Glembotski CC; Vernallis AB; Heath JK; Pennica D; Wood WI; Chien KR
    J Biol Chem; 1996 Apr; 271(16):9535-45. PubMed ID: 8621626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: a meta-analysis.
    Song K; Wang S; Huang B; Luciano A; Srivastava R; Mani A
    J Clin Hypertens (Greenwich); 2014 Sep; 16(9):686-92. PubMed ID: 25052897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.